Use access key #2 to skip to page content.
$15.72 0.55 (3.63%)
7/8/2008 4:04 PM

Dr. Reddy's Laboratories Limited (ADR) (RDY)

CAPS Rating:
*****

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating RDY

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

307 Outperforms
15 Underperforms
 

All-Stars

84 Outperforms
3 Underperforms
 

Wall Street

1 Outperforms
1 Underperforms
 

Players bullish on RDY are also bullish on:

Players bearish on RDY are also bearish on:

Ticker Tags

Small Cap (1922), Drug Manufacturers - Other (105), India (27)
Suggest a tag

Dr. Reddy's Laboratories Limited (ADR) At A Glance

Current Price: $15.72
Last Trade Time: 7/8/2008 4:04 PM
Open: $15.09
Previous Close: $15.17
Daily Range: $15.09 - $15.72
52-Week Range: $13.07 - $18.66
Volume: 202,253
Market Cap: $2.55B
P/E Ratio: 21.99
Compare Our Special Broker Offers!

Stock Trends

RDY VS S&P 500 (SPY)

RDY 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

1

Dr. Reddy's Laboratories Limited (ADR) (RDY)

Avatar 21popsontop (< 20) Submitted: 2/04/08 2:07 AM

India's growth will only gain more ground in the global markets. This company will be one of its many top performers over time.Has already started paying dividend yield.Just kicked off in september 2007 in the OTC drug market with U.S.,and will be launching several new products in up coming quarters...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 56 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (RDY)

Avatar catbert234 (66.03) Submitted: 7/03/08 9:06 AM : Outperform Start Price: $14.40 RDY Score: 9.10

Generic drug strategies are a winner in an economy poised to move toward single payer health care with a bias toward lower-cost meds to save economic $$$'s.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RDY)

Avatar mrsudbury (69.68) Submitted: 6/14/08 8:09 PM : Outperform Start Price: $16.50 RDY Score: 1.96

seems like a good long term sector favourite with room for upside.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RDY)

Avatar fellowme (< 20) Submitted: 6/09/08 3:34 PM : Outperform Start Price: $15.82 RDY Score: 5.98

right time to start grabbing this indian pharma giant...master at grabbing share of generic markets and baby boomers coming in...tentative nod for omeprazole ...down majorly due to german business in last couple of quarter...poised to grow with new product launches and acqusitions....

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RDY)

Avatar ak2k8 (28.00) Submitted: 4/18/08 11:23 AM : Outperform Start Price: $15.57 RDY Score: 9.28

Dr.Reddy's is (in)famous for picking up drugs immediately after the patents expire and minting money. They are into generic drugs. with Walmart's $4 drugs, the demand for generic drugs from overseas is high. I wouldn't trust the chinese to give me medicine but Indian Pharma industry is quite well developed. Dr.Reddy's Labs makes good money domestically as well as through exports to Americas and Africa. With generic drugs, cost is the only barrier with no much research required.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RDY)

Avatar ResearchLover (93.53) Submitted: 4/16/08 12:26 PM : Outperform Start Price: $15.25 RDY Score: 9.27

I like the recent uptrend and am going with short term momentum. And TMFSarahGen says its a good time to look at biotech/pharma. Others say look for the companies making tools for biotech and intermediates/ingredients puts this one with my existing long term pick SIAL. I may hold this one indefinitely or trade on volatility of the India market.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 56 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackCreditSuiss 95.19 06/13/07 Outperform NS $15.36+2.34%-15.48%+17.82
TrackJimCramer 83.15 10/12/06 Underperform 3W $15.37+2.28%-6.98%-9.25

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners